News Daily News Small Fraction of STEMI Patients With Shock Meet DanGer Criteria Caitlin E. Cox October 11, 2024
News Daily News SCAI Releases Practical, Technical Advice for Primary PCI in STEMI Michael O'Riordan October 10, 2024
News Daily News Different Guidelines for Acute PE Offer a Mixed Bag of Advice Caitlin E. Cox October 08, 2024
News Daily News Little Pre- and Postmarket Testing for Most Recalled CV Devices Michael O'Riordan September 16, 2024
News Daily News FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients L.A. McKeown August 21, 2024
News Daily News Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF Michael O'Riordan July 26, 2024
News Daily News PCI Complications Portend Dire Outcomes: Tracking Could Be Key Caitlin E. Cox July 25, 2024
News Daily News Early, Intense GDMT Improves Decongestion in Acute HF: STRONG-HF Todd Neale July 19, 2024
News Daily News Everyone’s Glum About RECOVER IV: Where Shock Care Heads Next Is Unclear Caitlin E. Cox July 03, 2024
News Daily News RECOVER IV Impella Trial Halted in the Wake of DanGer Shock Caitlin E. Cox June 18, 2024
News Daily News HeartMate 3 Recalled for Risk of Blood Leaks or Air in System L.A. McKeown May 15, 2024
News Daily News FDA Expresses Continuing Concerns About Getinge/Maquet CV Devices Todd Neale May 08, 2024
News Daily News HeartMate II and 3 LVADs Recalled Due to Potential for Outflow Graft Obstruction Caitlin E. Cox April 22, 2024
News Daily News Abiomed Recalls Labeling for Left-Sided Impella Pumps: FDA Caitlin E. Cox March 21, 2024
News Daily News New Risk Score Better for Capturing Medical Urgency for Heart Transplantation Michael O'Riordan February 19, 2024
News Daily News Lengthy CPR for In-Hospital Cardiac Arrest Tied to Worse Outcomes Caitlin E. Cox February 12, 2024
News Daily News Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER Michael O'Riordan February 08, 2024
News Daily News AHA Details Cath Lab’s Role in Out of Hospital Cardiac Arrest Caitlin E. Cox January 02, 2024
News Daily News Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients L.A. McKeown January 02, 2024